Plus therapeutics and biocept announce comprehensive laboratory services agreement for the respect-lm trial

Biocept's cnside™ assay provides a highly sensitive method to assess and quantify tumor cell burden in leptomeningeal metastasis (lm) of the central nervous system

PSTV Ratings Summary

PSTV Quant Ranking